Home › Kanser sa Buto
Pag-aaral pangklinika para sa Kanser sa Buto na nagre-recruit sa U.S.
19 pag-aaral para sa Kanser sa Buto ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
Ayos sa estado
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07193550Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07215611Bridging Adolescent and Young Adult Sarcoma Survivors With Personalized Oncology Exercise Service (AYA-ONE): A Pilot Intervention
Nagre-recruit
Edad 15 hanggang 39 · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT07662239Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT03965234Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma
Nagre-recruit
Lahat ng edad · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT07514819Evaluation of Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography in Patients With Sarcoma
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT06409013U.S. Prospective Evaluation of EPIONE Device for Percutaneous MSK Procedures
Nagre-recruit
Edad 22 pataas · Lahat ng kasarian · Na-update Hul 20, 2026 · NCT07325578Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
Nagre-recruitPhase 1
Edad 12 hanggang 50 · Lahat ng kasarian · Na-update Hul 15, 2026 · NCT03093909XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 18, 2026 · NCT06571734Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone Metas
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 2, 2026 · NCT05419518Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma
Nagre-recruitPhase 2
Edad 8 hanggang 30 · Lahat ng kasarian · Na-update May 22, 2026 · NCT05726383Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update May 15, 2026 · NCT06129903Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update May 14, 2026 · NCT07197645Mg OSTEOCRETE Post-Treatment Outcomes
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 22, 2026 · NCT06720142Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
Nagre-recruitObservasyonal na pag-aaral
Edad 4 pataas · Lahat ng kasarian · Na-update Abr 17, 2026 · NCT03442465Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone
Nagre-recruitObservasyonal na pag-aaral
Edad 15 pataas · Lahat ng kasarian · Na-update Mar 13, 2026 · NCT05033288An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 11, 2026 · NCT02677961Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Lahat ng edad · Lahat ng kasarian · Na-update Okt 15, 2025 · NCT03160274Definitive Radiation for High-Risk Spine Metastases
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update May 14, 2025 · NCT06165419Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.